Correlation Between Larimar Therapeutics and MorphoSys

Can any of the company-specific risk be diversified away by investing in both Larimar Therapeutics and MorphoSys at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Larimar Therapeutics and MorphoSys into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Larimar Therapeutics and MorphoSys AG ADR, you can compare the effects of market volatilities on Larimar Therapeutics and MorphoSys and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Larimar Therapeutics with a short position of MorphoSys. Check out your portfolio center. Please also check ongoing floating volatility patterns of Larimar Therapeutics and MorphoSys.

Diversification Opportunities for Larimar Therapeutics and MorphoSys

-0.03

Correlation Coefficient

Larimar Therapeutics  MorphoSys

Good diversification

The 3 months correlation between Larimar and MorphoSys is -0.03. Overlapping area represents the amount of risk that can be diversified away by holding Larimar Therapeutics and MorphoSys AG ADR in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on MorphoSys AG ADR and Larimar Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Larimar Therapeutics are associated (or correlated) with MorphoSys. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of MorphoSys AG ADR has no effect on the direction of Larimar Therapeutics i.e., Larimar Therapeutics and MorphoSys go up and down completely randomly.

Pair Corralation between Larimar Therapeutics and MorphoSys

Given the investment horizon of 90 days Larimar Therapeutics is expected to generate 3.07 times more return on investment than MorphoSys. However, Larimar Therapeutics is 3.07 times more volatile than MorphoSys AG ADR. It trades about 0.18 of its potential returns per unit of risk. MorphoSys AG ADR is currently generating about 0.02 per unit of risk. If you would invest  786.00  in Larimar Therapeutics on March 10, 2024 and sell it today you would earn a total of  173.00  from holding Larimar Therapeutics or generate 22.01% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	100.0%
Values	Daily Returns

Larimar Therapeutics  vs.  MorphoSys AG ADR

Larimar Therapeutics

Risk-Adjusted Performance

4 of 100

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Larimar Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent primary indicators, Larimar Therapeutics reported solid returns over the last few months and may actually be approaching a breakup point.

MorphoSys AG ADR

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days MorphoSys AG ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, MorphoSys is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Larimar Therapeutics and MorphoSys

The main advantage of trading using opposite Larimar Therapeutics and MorphoSys positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Larimar Therapeutics position performs unexpectedly, MorphoSys can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in MorphoSys will offset losses from the drop in MorphoSys' long position.

The idea behind Larimar Therapeutics and MorphoSys AG ADR pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.